Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > We have superior data. Catch-up will happen

<< Previous

Bullboard Posts

Next >>

Comment by DeathXray33on May 04, 2023 5:44pm

141 Views

Post# 35431357

RE:We have superior data. Catch-up will happen

ScienceFirst wrote:
Hard for any of us to envision higher share price despite all our beliefs that this technology should be valued much higher. The official signal by management has been set when we reached the FDA milestone of p#25 @450-days and via the Jan. 3rd article. It was though hinted in the Feb. 7 2022 corporate presentation that 2023 would be projected as a transformative year.

Before the final surge, these stocks have been battered. And take some spikes and you'll notice that a 10x spike happens quite often. For example, for IMGN:

June 2008 (140M$) - Jul 2013 (1.6B$)
Nov 2016 (160M$) - Feb 2018 (1.5B$)
May 2019 (270M$) - Feb 2021 (1.7B$)

We are starting much lower, so have ample room for upside. We simply need this big pharma partner that will believe in our ACT platform. It's their call.

https://companiesmarketcap.com/iveric-bio/marketcap/

https://companiesmarketcap.com/immunogen/marketcap/